Department of Ultrasound, Qiqihar Hospital Affiliated to Southern Medical University, Qiqihar City, Heilongjiang Province, China.
Department of Ultrasound, First Affiliated Hospital of China Medical University, Shenyang City, Liaoning Province, China.
Ultrasound Med Biol. 2021 Oct;47(10):2839-2852. doi: 10.1016/j.ultrasmedbio.2021.06.005. Epub 2021 Jul 22.
In recent years, the in-depth study of low-frequency sonophoresis (LFS) has greatly elucidated its biological effects in various therapeutic applications, including drug delivery, enhanced healing, thrombolytic technology, anti-inflammatory effects and tumor treatment. Specifically, numerous studies have reported its use in drug delivery and synergistic antitumor activity, indicating a new treatment direction for cancer. However, there are significant gaps in the understanding of LFS in terms of frequency and sound intensity safety; these issues are becoming increasingly important in understanding the biological effects of LFS ultrasound. This article reviews the treatment mechanism and current applications of LFS technology and discusses and summarizes its safety and application prospects.
近年来,低频超声(LFS)的深入研究极大地阐明了其在各种治疗应用中的生物学效应,包括药物输送、增强愈合、溶栓技术、抗炎作用和肿瘤治疗。具体来说,许多研究报告了它在药物输送和协同抗肿瘤活性中的应用,为癌症治疗提供了新的方向。然而,在 LFS 的频率和声强安全性方面,人们对其的理解仍存在显著差距;这些问题在理解 LFS 超声的生物学效应方面变得越来越重要。本文综述了 LFS 技术的治疗机制和当前应用,并讨论和总结了其安全性和应用前景。